Several studies have shown that secreted clusterin (sCLU) up-regulation inmulti-drug resistant osteosarcoma (OS) cells relates to enhanced drug resistance.Furthermore, sCLU silencing directed against sCLU induces significant reduction ofcellular growth and sensitizes OS cells to chemotherapy. The gene discussed is CLU; the disease is osteosarcoma.